HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.

AbstractBACKGROUND:
Development of distant metastases (DM) is associated with markedly decreased survival in parathyroid carcinoma (PC). We sought to identify factors associated with development of DM and to quantify the effect that development of DM had on overall survival (OS).
METHODS:
Patients with surgically resected local/regional PC treated or surveilled at a tertiary-referral cancer hospital from 1980 to 2017 were included. We assessed the association between biochemical and clinicopathologic factors (preoperative parathyroid hormone (PTH) levels, sex, race, age, preoperative serum calcium levels, serum calcium levels at 6 months postop, tumor size, and extent of resection) with the development of DM. We also assessed the effect of development of DM on OS.
RESULTS:
Seventy-five patients with PC were assessed; 17 (22.7%) developed DM at a median follow-up of 77 months. The cumulative incidence of DM in the cohort was 20, 30, and 38% at 5, 10, and 20 years respectively. Tumor size > 3.2 cm based on recursive partitioning analysis was the only significant predictor for development of DM (hazard ratio (HR) = 3.51; 95% confidence interval [CI] 1.04-11.91; p = 0.04). Median OS for the entire cohort was 17 years compared with 40 months for the cohort who developed DM. The HR for death after distant metastasis was 9.6 (95% CI 4.2-22.3; p < 0.0001).
CONCLUSIONS:
Development of distant metastasis during surveillance is associated with decreased OS, including late recurrences. Primary tumor size should be considered in future interval surveillance and development of treatment algorithms.
AuthorsElliot A Asare, Angelica Silva-Figueroa, Kenneth R Hess, Naifa Busaidy, Paul H Graham, Elizabeth G Grubbs, Jeffrey E Lee, Michelle D Williams, Nancy D Perrier
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 26 Issue 11 Pg. 3593-3599 (Oct 2019) ISSN: 1534-4681 [Electronic] United States
PMID31111352 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Bone Neoplasms (mortality, secondary, surgery)
  • Female
  • Follow-Up Studies
  • Hospitals, High-Volume (statistics & numerical data)
  • Humans
  • Liver Neoplasms (mortality, secondary, surgery)
  • Lung Neoplasms (mortality, secondary, surgery)
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Parathyroid Neoplasms (mortality, pathology, surgery)
  • Prognosis
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: